Get startedLog in
    Picture of Neuromeka Co logo

    348340 — Neuromeka Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    IndustrialsHighly SpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Neuromeka Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-8,271-6,594-8,201-17,654-16,755
    Depreciation
    Amortisation
    Non-Cash Items2,1674,7501,0305,378718
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital1,113-101-1,729-1,165-8,215
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-4,016-1,056-7,999-12,434-21,930
    Capital Expenditures-299-293-3,323-30,601-13,787
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items2,489-4,335-15,938-15,79830,355
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities2,190-4,628-19,261-46,40016,568
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities4,37313,49726,11357,11315,371
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2,5547,831-1,149-1,72610,068